Keywords: Diagnosis/Prediction, Radiomics, Breast neoplasms; Peritumoral; Neoplasm recurrence; Image interpretation
Motivation: 21-gene assay is recommend to guide decision on the use of adjuvant chemotherapy. However, this test is expensive and time-consuming, so it is not widely used in clinic.
Goal(s): To develop a radiomics model for predicting 21-gene recurrence score based on MRI intratumoral and peritumoral features.
Approach: Prediction models in tumor and different peritumoral regions (2 mm, 4 mm, 6 mm, 8 mm, 10 mm) were established using machine learning method. Feature-fusion and logistics-regression methods were used to fuse information.
Results: Combining 4-mm peritumoral model on T2WI (AUC = 0.66) with intratumoral and clinical-imaging features, the fusion model performed best (AUC = 0.75).
Impact: To provide an alternative for patients who cannot afford Oncotype 21-gene assay and to reduce the medical costs for those who could afford it.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords